Results 241 to 250 of about 106,373 (291)

[Chemotherapy of urologic neoplasms--experimental approach and clinical application].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1986
openaire   +1 more source

Multiple primary malignant neoplasms in urologic patients

International Urology and Nephrology, 2003
Second primary cancers constitute approximately 9-10% of malignancies diagnosed in the United States. We aimed to show the risk and incidance of second primary tumor occuring associated to urologic tumors and show the distrubution of tumors in Tracia region. We retrospectively examined the patients' files with the diagnosis of malignant disease between
Inci, Osman, Kaya, Esat, Alagol, Bulent, Atakan, Irfan Huseyin, Aydin, Sabahattin, Ereselli, Hasan   +5 more
core   +5 more sources

Some of the next articles are maybe not open access.

Related searches:

Autopsy findings of patients with urological neoplasms

International Journal of Clinical Oncology, 2002
A study was carried out to gain extensive understanding of the disease status in patients who had suffered and died of urological neoplasms.The subjects were 524 patients who had died at the Department of Urology of Gunma Cancer Center. The autopsy rate for each urological, neoplasm, the extent of the disease, and incidental diseases were analyzed ...
Yoshihiro, Ono, Masashi, Ozawa, Koichi, Suzuki, Hiroshi, Okazaki, Yoshimi, Tamura, Takanori, Suzuki, Kazuhiro, Suzuki, Akira, Ogawa, Shiro, Sugihara   +8 more
openaire   +2 more sources

Multiple Primary Malignant Neoplasms in Urologic Patients

Scandinavian Journal of Urology and Nephrology, 1995
One hundred and four patients with multiple primary malignant neoplasm (MPN) with at least one genitourinary organ involved were analyzed. The 104 patients represented 0.9% of all cancer patients and 9.0% of all urologic tumor cases. Tumors of the prostate and bladder in urologic cancers and tumors of the gastrointestinal tract, particularly stomach ...
K, Koyama, Y, Furukawa, H, Tanaka
openaire   +2 more sources

Reproducibility and reliability of tumor grading in urological neoplasms

World Journal of Urology, 2007
Histopathologic tumor grading reflects the degree of differentiation of a given tumor and for most urological tumors grading is an important factor in predicting their biological aggressiveness. Consequently, the clinical management of tumor patients is often strongly influenced by the tumor grade, provided by pathologists.
openaire   +2 more sources

[Urologic neoplasms in AIDS].

Actas urologicas espanolas, 1992
Report on 2 cases of urological neoplasia in HIV positive patients. The first one is a renal adenocarcinoma in a heroin-abuser patient, of a type we have only found mentioned in the literature in 4 other cases. The second case was a disseminated Kaposi's sarcoma, the first symptom being a scrotum impairment and the biopsy suggested the diagnosis.
V, Montserrat, L, Muntaner, A, Mus, E, Serra, A, Conte, V, Torroella, C, Gutierrez, M, Ozonas   +7 more
openaire   +1 more source

Leiomyomata of the genitourinary tract: A case series from the “rare urological neoplasm” registry [PDF]

Scandinavian Journal of Urology, 2012
Leiomyomata are benign neoplasms that are rarely encountered in the genitourinary tract outside the uterus. Pathological confirmation is always needed for definitive diagnosis, in order to rule out malignancies such as leiomyosarcoma. In cases of small leiomyomata, a surveillance strategy can be suggested, although the preferred approach is complete ...
ODERDA, Marco, Mondaini N, Bartoletti R, Vigna D, Fiorito C, Marson F, Peraldo F, Bosio A, Maletta F, Pacchioni D, GONTERO, Paolo   +10 more
openaire   +3 more sources

[The chemotherapy of urologic neoplasms].

Helvetica chirurgica acta, 1978
The newest aspects for the use of cytostatic agents in the treatment of bladder, prostatic and testicular carcinomas are presented. Especially the two new drugs diaminodichlor cisplatinum and adriamycin are discussed as to their potential use in these diseases.
openaire   +1 more source

[Advance in the immunologic study of urologic neoplasms].

Archivos espanoles de urologia, 1980
The reduction of the levels of circulating T lymphocytes in urological neoplasias seems obvious. The existence of a link between the different, neoplastic, bladder and prostate processes, as well as the degree of malignancy, prognosis and therapeutic response has still to be established, according to the immunitary state of the patients.
F, Pérez Herrero, M, Urrutia, V, Vidal Catalá, J, Montero Gómez   +3 more
openaire   +1 more source